| Stage | ACN | % of rev | IBM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $18.7B | 100.00% | $17.1B | 100.00% | ACN ×1.09 |
| Gross profit | $6.0B | 32.04% | $9.7B | 56.80% | IBM +24.8pp |
| Operating income | $2.9B | 15.33% | $3.0B | 17.48% | IBM +2.1pp |
| Pre-tax income | $2.8B | 14.98% | $2.5B | 14.60% | ACN +0.4pp |
| Net income | $2.0B | 10.89% | $2.2B | 12.80% | IBM +1.9pp |
| Stage | ACN | IBM | Gap · A − B |
|---|---|---|---|
| Revenue | $18.7B100.00% | $17.1B100.00% | ACN ×1.09 |
| Gross profit | 32.04%$6.0B | 56.80%$9.7B | IBM +24.8pp |
| Operating income | 15.33%$2.9B | 17.48%$3.0B | IBM +2.1pp |
| Pre-tax income | 14.98%$2.8B | 14.60%$2.5B | ACN +0.4pp |
| Net income |
| 10.89%$2.0B |
| 12.80%$2.2B |
| IBM +1.9pp |
No shared counterparties.